Akili Grabs CE Mark for Children’s Digital ADHD Treatment Post author:Sam Post published:June 22, 2020 Post category:Devices & Diagnostics Letter The FDA last week cleared EndeavorRx for marketing in the U.S. Source: Devices & Diagnostics Letter You Might Also Like Three More States Pursue Drug Price Controls February 21, 2020 FDA Warns Canadian Sterile Drugmaker for Aseptic Practices June 22, 2020 AstraZeneca Receives $1.2 Billion BARDA Contract for COVID-19 Vaccine May 21, 2020
